NCT01974739
Completed
Not Applicable
Hypernatraemia and Diuretics in Intensive Care Patients
Medical Centre Leeuwarden1 site in 1 country50 target enrollmentSeptember 2013
Overview
- Phase
- Not Applicable
- Intervention
- Hydrochloorthiazide
- Conditions
- Hypernatraemia
- Sponsor
- Medical Centre Leeuwarden
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- sodium level
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
Acquired hypernatremia appears to be associated with mortallity in ICU. To reduce hypernatremia and shorten the time of hypernatremia, we investigate the effect of hydrochloorthiazide compared to a placebo
Investigators
E.C. Boerma
MD PhD
Medical Centre Leeuwarden
Eligibility Criteria
Inclusion Criteria
- •sodium \> 142
Exclusion Criteria
- •no informed consent
Arms & Interventions
hydrochloorthiazide
once a day 25 mg
Intervention: Hydrochloorthiazide
placebo
once a day placebo
Intervention: placebo
Outcomes
Primary Outcomes
sodium level
Time Frame: 7 days
a decrease of 5 mmol/L sodium in plama
Secondary Outcomes
- time hypernatraemia(7 days)
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Prospective Analysis Into Development of Hypernatremia in Critically Ill PatientsHypernatremiaCritical IllnessNCT05085223Catharina Ziekenhuis Eindhoven1,500
Completed
Not Applicable
Prospective Data Analysis of the Development of Hypernatremia in Intensive Care UnitHypernatremiaNCT03752450Catharina Ziekenhuis Eindhoven200
Withdrawn
Not Applicable
Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective DiuresisRespiratory FailureVolume OverloadHypernatremiaNCT01617798Oregon Health and Science University
Recruiting
Not Applicable
Plasma Sodium and Sodium Administration in the ICUHypernatremiaHyponatremiaCritical IllnessNCT06037928University Hospital, Linkoeping200
Active, not recruiting
Not Applicable
Hypernatraemia and diureticsIntensive Care admissionsodium level in plasma > 142 mmol/LTherapeutic area: Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]EUCTR2013-002165-19-NLMedical Center Leeuwarden